Kwality Pharmaceuticals Limited (BOM:539997)
India
· Delayed Price · Currency is INR 755.00
-42.10 (-5.28%)
At close: Apr 24, 2025
Kwality Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | - | 237.96 | 193.72 | 1,200 | 151.46 | 83.17 | Upgrade
|
| Depreciation & Amortization | - | 195.59 | 149.58 | 106.91 | 64.93 | 44.34 | Upgrade
|
| Other Amortization | - | - | - | - | 0.35 | 0.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.02 | -0.54 | - | 0.2 | -1.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 3.9 | Upgrade
|
| Other Operating Activities | - | 230.67 | 60.91 | 30.91 | 22.88 | 21.65 | Upgrade
|
| Change in Accounts Receivable | - | -426.91 | -25.64 | - | -53.8 | 80.97 | Upgrade
|
| Change in Inventory | - | 27.35 | -329.54 | -359.96 | 50.52 | -111.7 | Upgrade
|
| Change in Accounts Payable | - | 91.25 | 6.78 | - | 32.49 | 58.97 | Upgrade
|
| Change in Other Net Operating Assets | - | 73.95 | 358.55 | -371.81 | -1.98 | -119.53 | Upgrade
|
| Operating Cash Flow | - | 429.83 | 413.82 | 605.97 | 267.05 | 61.65 | Upgrade
|
| Operating Cash Flow Growth | - | 3.87% | -31.71% | 126.91% | 333.20% | -54.59% | Upgrade
|
| Capital Expenditures | - | -298.41 | -476.73 | -551.52 | -234 | -207.79 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 41.12 | 18.63 | - | 1.44 | 28.46 | Upgrade
|
| Investment in Securities | - | - | - | - | -1.29 | 2.26 | Upgrade
|
| Other Investing Activities | - | -6.67 | -26.3 | -77.75 | 1.81 | -0.91 | Upgrade
|
| Investing Cash Flow | - | -263.97 | -484.41 | -629.28 | -232.03 | -177.98 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 3,579 | 2,505 | Upgrade
|
| Long-Term Debt Issued | - | 40.56 | 115.48 | 85.74 | 151.68 | 162.5 | Upgrade
|
| Total Debt Issued | - | 40.56 | 115.48 | 85.74 | 3,731 | 2,667 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -3,646 | -2,479 | Upgrade
|
| Long-Term Debt Repaid | - | -112.59 | -45.34 | - | -50.92 | -44.91 | Upgrade
|
| Total Debt Repaid | - | -112.59 | -45.34 | - | -3,697 | -2,524 | Upgrade
|
| Net Debt Issued (Repaid) | - | -72.03 | 70.14 | 85.74 | 34.39 | 142.71 | Upgrade
|
| Other Financing Activities | - | -101.95 | -60.2 | -29.17 | -26.72 | -24.99 | Upgrade
|
| Financing Cash Flow | - | -173.98 | 9.94 | 56.57 | 7.67 | 117.72 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | - | -8.12 | -60.65 | 33.26 | 42.7 | 1.38 | Upgrade
|
| Free Cash Flow | - | 131.42 | -62.92 | 54.45 | 33.06 | -146.14 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 64.69% | - | - | Upgrade
|
| Free Cash Flow Margin | - | 4.28% | -2.51% | 1.19% | 1.26% | -10.26% | Upgrade
|
| Free Cash Flow Per Share | - | 12.66 | -6.06 | 5.25 | 3.19 | -14.09 | Upgrade
|
| Cash Interest Paid | - | 101.95 | 60.2 | 29.17 | 26.72 | 24.99 | Upgrade
|
| Cash Income Tax Paid | - | 13 | 61.56 | 413.54 | 63.84 | 27.1 | Upgrade
|
| Levered Free Cash Flow | - | -130.94 | -258.69 | -225.56 | -28.71 | -207.28 | Upgrade
|
| Unlevered Free Cash Flow | - | -66.02 | -221.06 | -207.33 | -11.99 | -191.64 | Upgrade
|
| Change in Net Working Capital | - | 266.03 | 185.66 | 779.59 | -8.67 | 109.61 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.